THE SUMMIT TEAM

Colin focuses primarily on the technology sector. His investments include Advanced Cell Diagnostics (acquired by Bio-Techne Corporation), Delphix, Gainsight, InfoArmor, JAMF Software, Podium, Reverb.com, RiskIQ, Rocket Fuel (NASDAQ: FUEL), TeleSign, TSheets, Uber and Wowza Media Systems.

Prior to Summit, Colin worked for Union Square Advisors, Accenture and Electronic Arts. He holds a BS in finance and marketing, with High Honors, from Lehigh University.